-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MOv18 IgE in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MOv18 IgE in Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MOv18 IgE in Breast Cancer Drug Details: MOv18 IgE is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MOv18 IgE in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MOv18 IgE in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MOv18 IgE in Ovarian Cancer Drug Details: MOv18 IgE is under...
-
Product Insights
T Cell Immunoreceptor With Ig And ITIM Domains – Drugs In Development, 2023
Global Markets Direct’s T Cell Immunoreceptor With Ig And ITIM Domains provides in depth analysis on T Cell Immunoreceptor With Ig And ITIM Domains targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
Sialic Acid Binding Ig Like Lectin 15 – Drugs In Development, 2023
Global Markets Direct’s Sialic Acid Binding Ig Like Lectin 15 provides in depth analysis on Sialic Acid Binding Ig Like Lectin 15 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
NewLikelihood of Approval Analysis for Type I Hypersensitivity
Overview How likely is it that the drugs in Type I Hypersensitivity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Type I Hypersensitivity Overview Type 1 hypersensitivity is a type of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IG-8801 in Chronic Low Back Pain (CLBP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IG-8801 in Chronic Low Back Pain (CLBP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IG-8801 in Chronic Low Back Pain (CLBP) Drug Details:...
-
Product Insights
NewLikelihood of Approval Analysis for Hypersensitivity
Overview How likely is it that the drugs in Hypersensitivity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypersensitivity Overview Hypersensitivity reactions (HR) are exaggerated immune responses categorized by Coombs and...
-
Product Insights
NewLikelihood of Approval Analysis for Allergic Rhino-Conjunctivitis
Overview How likely is it that the drugs in Allergic Rhino-Conjunctivitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Allergic Rhino-Conjunctivitis Overview Allergic Rhino-Conjunctivitis is an allergen-induced inflammatory response mediated by...
-
Company Insights
Innovation and Patenting activity of IG Group Holdings Plc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of IG Group Holdings Plc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Company Insights
Innovation and Patenting activity of IG Design Group plc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of IG Design Group plc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...